表紙
市場調查報告書

新興市場上醫藥品企業·保險者間的合作

Pharma-Payer Partnerships in Emerging Markets

出版商 Datamonitor Healthcare 商品編碼 570533
出版日期 內容資訊 英文 72 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
新興市場上醫藥品企業·保險者間的合作 Pharma-Payer Partnerships in Emerging Markets
出版日期: 2017年08月14日內容資訊: 英文 72 Pages
簡介

本報告提供新興市場上醫藥品企業·保險者間的合作環境相關調查,提供和保險者合作的優點,各種合作選擇,彙整醫療費用自己負擔市場及給付制度的市場上合作分析,重要成功因素分析等資料。

摘要整理

  • 與支付者的合作關係促進打入新興市場
  • 與付款人的合作關係有多種形式,取決於資金來源
  • 定制化是自我支付市場成功合作的關鍵
  • 即使在有給付制度的新興市場中成果付款也稀少
  • 最成功的伙伴關係是當地水準的推動

醫藥品企業·保險者的合作環境

  • 保險者的合作正在打開新興市場的市場機會
  • 市場結構塑造了合作關係
  • 文獻

醫療費自我負擔在新興市場上的合作

  • 醫療費自我負擔市場:合作選擇的摘要
  • 捐獻的合作
  • 分層定價
  • 持續治療計劃
  • 補充健康保險
  • 文獻

有給付制度的新興市場上合作

  • 服務支援推動打入市場
  • 現實世界evidence氣勢漸增
  • 風險共享
  • 技術轉移
  • 文獻

重要成功因素

  • 與當地目標和能力協調一致是關鍵
  • 各種合作選擇的風險/利潤分析

附錄

目錄
Product Code: DMKC0176385

Payer partnerships are becoming widespread as emerging markets become wealthier, but access challenges remain. Partnerships with proven success include "strategic philanthropy," patient access programs, tiered pricing, and service support models. Many of the most successful strategies are hybrids of two or more "pure" partnership archetypes.

This analysis is a survey of recent industry experience with payer partnerships in emerging markets, using case studies and real-world exemplars to illustrate best practice. While there is no "one size fits all" approach to partnering in emerging markets, Datamonitor Healthcare has considered in each case how best to address payer needs that cannot be served by the routine course of business.

This analysis covers self-pay markets, partially reimbursed, and reimbursed emerging markets. Pharmaceutical companies that can overcome payer resistance, and take a proactive approach, can reap significant rewards from innovative partnerships in challenging, high-growth markets.

TABLE OF CONTENTS

5. EXECUTIVE SUMMARY

  • Partnerships with payers facilitate access in emerging markets
  • Partnerships with payers take many forms, depending on funding source
  • Customization is key for successful partnerships in self-pay markets
  • Even in reimbursed emerging markets, paying for outcomes is rare
  • The most successful partnerships are driven at the local level

7. THE PHARMA-PAYER PARTNERSHIPS LANDSCAPE

  • Payer partnerships are unlocking emerging-market opportunities
  • The market structure shapes the partnership
  • Bibliography

12. PARTNERSHIPS IN SELF-PAY EMERGING MARKETS

  • Self-pay markets: summary of partnership options
  • Donation partnerships
  • Tiered pricing
  • Continuous treatment programs
  • Complementary health insurance
  • Bibliography

41. PARTNERSHIPS IN REIMBURSED EMERGING MARKETS

  • Service support can boost access in reimbursed markets
  • Real-world evidence is gaining traction in emerging markets
  • Risk sharing in reimbursed emerging markets
  • Technology transfer in emerging markets
  • Bibliography

65. CRITICAL SUCCESS FACTORS FOR PARTNERSHIPS IN EMERGING MARKETS

  • Aligning partnerships with local goals and capabilities is key
  • Assessing risk-reward in partnering options

70. APPENDIX

  • About the author
  • Methodology

LIST OF FIGURES

  • Figure 1: Payer partnership options in emerging markets
  • Figure 2: Donation/tiered pricing archetype
  • Figure 3: Novartis access differentiated strategy
  • Figure 4: Continuous treatment program archetype
  • Figure 5: Discount card archetype (variant of CTP model)
  • Figure 6: Complementary insurance partnership archetype
  • Figure 7: Stakeholder map of Turkey
  • Figure 8: Outcomes-based risk sharing archetype
  • Figure 9: Stakeholder map of Mexico
  • Figure 10: Technology transfer archetype (Brazilian Partnerships for Productive Development model)
  • Figure 11: Requirements for emerging-market payer partnerships

LIST OF TABLES

  • Table 1: Risk-benefit matrix: partnerships in self-pay markets
  • Table 2: Case study 1: The Max Foundation
  • Table 3: Case study 2: Novartis Philippines and Roche Egypt
  • Table 4: Case study 3: Sanofi's emerging-market partnerships
  • Table 5: Case study 4: PAPs in Argentina
  • Table 6: Case study 5: Complementary insurance programs in China
  • Table 7: Case study 6: Payer support programs in Latin America
  • Table 8: Case study 7: Risk sharing in three Latin American markets
  • Table 9: Case study 8: Technology transfer programs in Brazil
  • Table 10: Options for payer partnerships by market archetype
Back to Top